Suraksha Diagnostic Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Suraksha Diagnostic will hold a meeting of the Board of Directors of the Company on 21 May 2026.

The key equity benchmarks traded with substantial losses in the mid-afternoon trade adopted a risk-off approach amid escalating geopolitical tensions following the US-Israel attacks on Iran. Traders are closely monitoring crude oil and metal prices. The Nifty slipped below the 24,800 level, reflecting weak market sentiment.

Media shares declined after advancing in the past trading session.

At 14:25 IST, the barometer index, the S&P BSE Sensex tanked 1,351.91 points or 1.66% to 79,911.22. The Nifty 50 index tumbled 420.15 points or 1.67% to 24,762.05.

In the broader market, the BSE 150 MidCap Index declined 1.79% and the BSE 250 SmallCap Index slipped 2.32%.

The market breadth was negative. On the BSE, 612 shares rose and 3,688 shares fell. A total of 167 shares were unchanged.

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rallied 27.23% to 17.44.

Buzzing Index:

The Nifty Media index fell 2.22% to 1,386.25. The index advanced 0.60% in the past trading session.

Hathway Cable & Datacom (down 5.13%), Zee Entertainment Enterprises (down 4.38%), D B Corp (down 3.89%), Nazara Technologies (down 3.53%), Sun TV Network (down 3.4%), Network 18 Media & Investments (down 2.55%), Saregama India (down 2.39%), Tips Music (down 2.27%), PVR Inox (down 1.79%) declined.

US-Iran Conflict:

The United States and Israel have launched major coordinated military strikes on Iran, marking a significant escalation in long-running Middle East tensions. On 1 March 2026, Iran launches missile and drone strikes on U.S. bases across six Middle Eastern countries amid escalating military tensions.

Iran?s Supreme Leader Ayatollah Ali Khamenei was reportedly killed in the attacks, escalating tensions further. Following his death, Iran appointed Ayatollah Alireza Arafi to its interim leadership council, which will assume charge of the country?s affairs.

Numbers to Track:

The yield on India's 10-year benchmark federal paper rose 0.54% to 6.697 compared with the previous session close of 6.661.

In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 91.4700 compared with its close of 91.0800 during the previous trading session.

MCX Gold futures for 2 April 2026 settlement gained 4.23% to Rs 168,950.

The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.83% to 98.42.

The United States 10-year bond yield jumped 0.18% to 3.965.

In the commodities market, Brent crude for May 2026 settlement surged $6.21 or 8.52% to $79.08 a barrel. amid heightened geopolitical tensions. According to media reports, Saudi Arabia?s state-owned oil major Aramco temporarily shut down its Ras Tanura refinery on Monday as a precautionary measure after an Iranian drone strike reportedly sparked a fire at the facility.

Stocks in Spotlight:

Suraksha Diagnostic fell 2.06% after its group chief financial officer (CFO) and key managerial personnel (KMP), K S Ravindra, has tendered his resignation due to personal reasons. The company said Ravindra will step down from his role on or before 31 May, 2026, close of business hours.

Powered by Capital Market - Live News

The company said Ravindra will step down from his role on or before 31 May, 2026, close of business hours.

In his resignation letter, Ravindra confirmed that there are no material reasons for his decision other than those stated.

The diagnostics services provider clarified that disclosures relating to appointment of director and relationship between directors are not applicable in this case, as the resignation pertains solely to the CFO position.

The company did not immediately announce a successor.

Suraksha Diagnostic offers integrated pathology and radiology testing, along with medical consultancy services.

The company had reported a 21% rise in consolidated net profit to Rs 7.24 crore on a 30.5% increase in total revenue from operations to Rs 77.69 crore in Q3 FY26 as compared with Q3 FY25.

Powered by Capital Market - Live News

Net profit of Suraksha Diagnostic rose 22.28% to Rs 7.52 crore in the quarter ended December 2025 as against Rs 6.15 crore during the previous quarter ended December 2024. Sales rose 30.55% to Rs 77.69 crore in the quarter ended December 2025 as against Rs 59.51 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News